Feasibility of prolonged use of interferon-alpha in metastatic kidney carcinoma: a phase II study.

@article{Kankuri2001FeasibilityOP,
  title={Feasibility of prolonged use of interferon-alpha in metastatic kidney carcinoma: a phase II study.},
  author={Minna Kankuri and T T Pelliniemi and Seppo Olavi Pyrh{\"o}nen and V{\"a}in{\"a}m{\"o} T. A. Nikkanen and Hans Y Helenius and Eeva K Salminen},
  journal={Cancer},
  year={2001},
  volume={92 4},
  pages={761-7}
}
BACKGROUND Interferon-alpha has proven effective in the treatment of metastatic renal cell carcinoma. However, the optimal schedule has not yet been determined. The authors have studied the efficacy and toxicity of prolonged use interferon-alpha2a (IFN-alpha) in metastatic renal cell carcinoma (RCC). Interferon-alpha was administered intermittently for outpatients. METHODS Seventy-five patients with metastatic RCC without prior biochemotherapy were treated. During the first month, the IFN… CONTINUE READING
Highly Cited
This paper has 22 citations. REVIEW CITATIONS